BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25571519)

  • 1. Sparse Principal Component Analysis for the parsimonious description of glucose variability in diabetes.
    Fabris C; Facchinetti A; Sparacino G; Cobelli C
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():6643-6. PubMed ID: 25571519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parsimonious Description of Glucose Variability in Type 2 Diabetes by Sparse Principal Component Analysis.
    Fabris C; Facchinetti A; Fico G; Sambo F; Arredondo MT; Cobelli C;
    J Diabetes Sci Technol; 2015 Jul; 10(1):119-24. PubMed ID: 26232371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis.
    Fabris C; Facchinetti A; Sparacino G; Zanon M; Guerra S; Maran A; Cobelli C
    Diabetes Technol Ther; 2014 Oct; 16(10):644-52. PubMed ID: 24956070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple Linear Support Vector Machine Classifier Can Distinguish Impaired Glucose Tolerance Versus Type 2 Diabetes Using a Reduced Set of CGM-Based Glycemic Variability Indices.
    Longato E; Acciaroli G; Facchinetti A; Maran A; Sparacino G
    J Diabetes Sci Technol; 2020 Mar; 14(2):297-302. PubMed ID: 30931604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and Prediabetes Classification Using Glycemic Variability Indices From Continuous Glucose Monitoring Data.
    Acciaroli G; Sparacino G; Hakaste L; Facchinetti A; Di Nunzio GM; Palombit A; Tuomi T; Gabriel R; Aranda J; Vega S; Cobelli C
    J Diabetes Sci Technol; 2018 Jan; 12(1):105-113. PubMed ID: 28569077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Should We Assess Glycemic Variability in Type 1 Diabetes? Contribution of Principal Component Analysis for Interstitial Glucose Indices in 142 Children.
    Guilmin-Crépon S; Carel JC; Schroedt J; Scornet E; Alberti C; Tubiana-Rufi N
    Diabetes Technol Ther; 2018 Jun; 20(6):440-447. PubMed ID: 29923773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycaemic variability-based classification of impaired glucose tolerance vs. type 2 diabetes using continuous glucose monitoring data.
    Longato E; Acciaroli G; Facchinetti A; Hakaste L; Tuomi T; Maran A; Sparacino G
    Comput Biol Med; 2018 May; 96():141-146. PubMed ID: 29573667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The continuous spectrum of glycaemic variability changes with pancreatic islet function: A multicentre cross-sectional study in China.
    Zhang L; Guo K; Tian Q; Ye J; Ding Z; Zhou Q; Wu J; Fan L; Pan N; Niu X; Zhao Q; Ma Y; Jiang H; Huang G; Li X; Zhou Z; Yang L
    Diabetes Metab Res Rev; 2022 Nov; 38(8):e3579. PubMed ID: 36214297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose Variability: A Review of Clinical Applications and Research Developments.
    Rodbard D
    Diabetes Technol Ther; 2018 Jun; 20(S2):S25-S215. PubMed ID: 29916742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.
    Rama Chandran S; Tay WL; Lye WK; Lim LL; Ratnasingam J; Tan ATB; Gardner DSL
    Diabetes Technol Ther; 2018 May; 20(5):353-362. PubMed ID: 29688755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes.
    Kovatchev B; Cobelli C
    Diabetes Care; 2016 Apr; 39(4):502-10. PubMed ID: 27208366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
    Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
    J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the mean absolute glucose change as a measure of glycemic variability using continuous glucose monitoring data.
    Kohnert KD; Heinke P; Fritzsche G; Vogt L; Augstein P; Salzsieder E
    Diabetes Technol Ther; 2013 Jun; 15(6):448-54. PubMed ID: 23550553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.
    Foreman YD; Brouwers MCGJ; van der Kallen CJH; Pagen DME; van Greevenbroek MMJ; Henry RMA; Koster A; Wesselius A; Schaper NC; Stehouwer CDA
    Diabetes Technol Ther; 2020 May; 22(5):395-403. PubMed ID: 31886732
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes.
    Chan CL; Pyle L; Morehead R; Baumgartner A; Cree-Green M; Nadeau KJ
    Pediatr Diabetes; 2017 Sep; 18(6):470-477. PubMed ID: 27503277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.
    Jin SM; Kim TH; Bae JC; Hur KY; Lee MS; Lee MK; Kim JH
    Diabetes Res Clin Pract; 2014 May; 104(2):266-72. PubMed ID: 24630619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report.
    Matsutani D; Sakamoto M; Iuchi H; Minato S; Suzuki H; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
    Cardiovasc Diabetol; 2018 Mar; 17(1):36. PubMed ID: 29514695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration.
    Piona C; Marigliano M; Mozzillo E; Franzese A; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
    Pediatr Diabetes; 2020 Dec; 21(8):1485-1492. PubMed ID: 32935887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous glucose monitoring to assess glucose variability in type 3c diabetes.
    Lee VTY; Poynten A; Depczynski B
    Diabet Med; 2022 Aug; 39(8):e14882. PubMed ID: 35569007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.